Russia Claims New Ebola Vaccine Amid Congo Crisis

Russia has announced that its scientists have developed a vaccine targeting a new Ebola strain, amidst rising global concern over the Bundibugyo Ebola outbreak in the Democratic Republic of Congo and Uganda. Health Minister Mikhail Murashko stated the vaccine may protect against the Bundibugyo strain, which currently lacks approved treatments. The World Health Organization (WHO) has classified this outbreak as a Public Health Emergency of International Concern due to fears of rapid spread across Central Africa.

Despite the announcement, international health experts stress the critical need for transparent clinical trial data and independent scientific validation before the vaccine can be widely adopted. The Bundibugyo strain is less common than the Zaire strain, against which the approved Ervebo vaccine is effective. While experimental vaccine candidates are under evaluation globally, robust data on Russia's new vaccine has not yet been publicly released. Health authorities continue to prioritize rapid detection, isolation, and surveillance to control the outbreak.